focus -WSS

focus

author：comprehensive 2025-09-29 18:17:43 - browse：27

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Pharma patents targeted by Biden in move to slash drug prices

WSS

After sickle

FDA needs staff influx to meet gene therapy needs, Marks says

After sickle

Color Health wants to make cancer screenings convenient

Are embryos people? Reproductive medicine's future depends on the answer

Readout Newsletter: Beam, Prozac, "TechBio" and more

leisure time

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

FDA needs staff influx to meet gene therapy needs, Marks says

Malaria cases in Florida and Texas: Here’s what you need to know

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

The high cost of giving birth even with insurance

Using force crossed my mind when examining a defiant young patient

New air purifier tech could be key to improving indoor air quality

Redefining sustainability for the pharmaceutical industry

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

entertainment

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Readout Newsletter: Beam, Prozac, "TechBio" and more

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Doctor of U.S. President Joe Biden says he is fit for duty

SCOTUS to consider access to abortion pill mifepristone

AI models in health care face new federal disclosure requirements

explore

leisure time

focus

focus